These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23086801)

  • 1. A novel regulatory defect in the branched-chain α-keto acid dehydrogenase complex due to a mutation in the PPM1K gene causes a mild variant phenotype of maple syrup urine disease.
    Oyarzabal A; Martínez-Pardo M; Merinero B; Navarrete R; Desviat LR; Ugarte M; Rodríguez-Pombo P
    Hum Mutat; 2013 Feb; 34(2):355-62. PubMed ID: 23086801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPM1K defects cause mild maple syrup urine disease: The second case in the literature.
    Ozcelik F; Arslan S; Ozguc Caliskan B; Kardas F; Ozkul Y; Dundar M
    Am J Med Genet A; 2023 May; 191(5):1360-1365. PubMed ID: 36706222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
    Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
    J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose transplant for inborn errors of branched chain amino acid metabolism in mice.
    Zimmerman HA; Olson KC; Chen G; Lynch CJ
    Mol Genet Metab; 2013 Aug; 109(4):345-53. PubMed ID: 23800641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of mutations, genotype-phenotype correlation and prenatal diagnosis of maple syrup urine disease in Indian patients.
    Gupta D; Bijarnia-Mahay S; Saxena R; Kohli S; Dua-Puri R; Verma J; Thomas E; Shigematsu Y; Yamaguchi S; Deb R; Verma IC
    Eur J Med Genet; 2015 Sep; 58(9):471-8. PubMed ID: 26257134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maple syrup urine disease. Complete defect of the E1 beta subunit of the branched chain alpha-ketoacid dehydrogenase complex due to a deletion of an 11-bp repeat sequence which encodes a mitochondrial targeting leader peptide in a family with the disease.
    Nobukuni Y; Mitsubuchi H; Akaboshi I; Indo Y; Endo F; Yoshioka A; Matsuda I
    J Clin Invest; 1991 May; 87(5):1862-6. PubMed ID: 2022752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients.
    Chuang JL; Davie JR; Chinsky JM; Wynn RM; Cox RP; Chuang DT
    J Clin Invest; 1995 Mar; 95(3):954-63. PubMed ID: 7883996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maple syrup urine disease caused by a partial deletion in the inner E2 core domain of the branched chain alpha-keto acid dehydrogenase complex due to aberrant splicing. A single base deletion at a 5'-splice donor site of an intron of the E2 gene disrupts the consensus sequence in this region.
    Mitsubuchi H; Nobukuni Y; Akaboshi I; Indo Y; Endo F; Matsuda I
    J Clin Invest; 1991 Apr; 87(4):1207-11. PubMed ID: 2010537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico prediction of the pathogenic effect of a novel variant of BCKDHA leading to classical maple syrup urine disease identified using clinical exome sequencing.
    Fernández-Lainez C; Aláez-Verson C; Ibarra-González I; Enríquez-Flores S; Carrillo-Sanchez K; Flores-Lagunes L; Guillén-López S; Belmont-Martínez L; Vela-Amieva M
    Clin Chim Acta; 2018 Aug; 483():33-38. PubMed ID: 29673582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel homozygous mutation (S144I) in a Malay patient with maple syrup urine disease.
    Ali EZ; Yunus ZM; Desa NM; Hock NL
    J Pediatr Endocrinol Metab; 2013; 26(9-10):975-80. PubMed ID: 23729548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of gene mutations among South Indian patients with maple syrup urine disease: identification of four novel mutations.
    Narayanan MP; Menon KN; Vasudevan DM
    Indian J Biochem Biophys; 2013 Oct; 50(5):442-6. PubMed ID: 24772966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new missense mutation in the BCKDHB gene causes the classic form of maple syrup urine disease (MSUD).
    Miryounesi M; Ghafouri-Fard S; Goodarzi H; Fardaei M
    J Pediatr Endocrinol Metab; 2015 May; 28(5-6):673-5. PubMed ID: 25381949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living related versus deceased donor liver transplantation for maple syrup urine disease.
    Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
    Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene analysis of maple syrup urine disease (MSUD)].
    Mitsubuchi H; Nobukuni Y; Hayashida Y; Ohta K; Indo Y; Akaboshi I; Endo F; Matsuda I
    Rinsho Byori; 1993 May; 41(5):484-91. PubMed ID: 8350511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex.
    Chuang DT; Fisher CW; Lau KS; Griffin TA; Wynn RM; Cox RP
    Mol Biol Med; 1991 Feb; 8(1):49-63. PubMed ID: 1943690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description of the mutations in 15 subjects with variant forms of maple syrup urine disease.
    Flaschker N; Feyen O; Fend S; Simon E; Schadewaldt P; Wendel U
    J Inherit Metab Dis; 2007 Nov; 30(6):903-9. PubMed ID: 17922217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a founder mutation for maple syrup urine disease in Hutterites.
    Mroch A; Davis-Keppen L; Matthes C; Stein Q
    S D Med; 2014 Apr; 67(4):141-3. PubMed ID: 24791375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of murine models of classic and intermediate maple syrup urine disease.
    Homanics GE; Skvorak K; Ferguson C; Watkins S; Paul HS
    BMC Med Genet; 2006 Mar; 7():33. PubMed ID: 16579849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of maple syrup urine disease in the Turkish population.
    Gorzelany K; Dursun A; Coşkun T; Kalkanoğlu-Sivri SH; Gökçay GF; Demirkol M; Feyen O; Wendel U
    Turk J Pediatr; 2009; 51(2):97-102. PubMed ID: 19480318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of the mutation responsible for maple syrup urine disease in Poll Shorthorns and genotyping Poll Shorthorns and Poll Herefords for maple syrup urine disease alleles.
    Dennis JA; Healy PJ
    Res Vet Sci; 1999 Aug; 67(1):1-6. PubMed ID: 10425233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.